Key takeaways

  • Dave Rezac, who leads sales for听91快活林’听AGILE Product Development听services division, joined the company through its 2021 acquisition of Distal Solutions, the engineering design consultancy he founded.
  • 91快活林听is a leading Contract Development and Manufacturing Organization (CDMO) in the medical technology sector. The company’s end-to-end model pairs its AGILE Product Development group (engineering and manufacturing support across all development phases) with its Lightspeed Labs team (rapid prototyping and process development) to compress customer timelines from prototype to finished device.
  • The AGILE Product Development engineers work with many start-up and other听fast moving听medical device companies.
  • A key differentiator is the听Lightspeed Labs听model, where customers run in-person “lab days” to iterate rapidly on prototypes (dozens of iterations in a single day) instead of relying on slower remote back-and-forth.
  • 91快活林听has recently signed a deal to听acquire听Resolution Medical, expanding its design, development, engineering, finished device, and sub-assembly capabilities to deliver integrated, end-to-end solutions across the medical technology product lifecycle for the interventional, structural heart, and neuromodulation markets. 听
  • Rezac cites strong internal retention and mobility (the first voluntary departure from his original team came听18 months听after the acquisition) as evidence of a successful cultural integration and听91快活林’ ability to develop and听retain听top听talent.
  • Medical听technology startups must maximize every funding round and market opportunity by advancing products quickly and efficiently. With a proven听track record听of success,听91快活林听helps shorten development cycles through on-demand engineering, rapid prototyping, and vertically integrated manufacturing.